Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Callen

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Human Genetics|May 19, 2004
The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 geneKavita Bhalla, Hilary A Phillips, Joanna Crawford, et al.
BMC Cancer|March 19, 2013
Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabineSue Ping Lim, Raman Kumar, Yamini Akkamsetty, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2012
Specific-site methylation of tumour suppressor ANKRD11 in breast cancerSue Ping Lim, Nick C Wong, Rachel J Suetani, et al.
American Journal of Medical Genetics|February 13, 2002
Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomaliesElizabeth Baker, Lyn Hinton, David F Callen, et al.
Journal of Cell Science|October 9, 2008
Identification of ANKRD11 as a p53 coactivatorPaul M Neilsen, Kelly M Cheney, Chia-Wei Li, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 23, 2013
Synthesis and extended activity of triazole-containing macrocyclic protease inhibitorsAshok D Pehere, Markus Pietsch, Michael Gütschow, et al.
Nucleic Acids Research|October 6, 2017
Naturally existing isoforms of miR-222 have distinct functionsFeng Yu, Katherine A Pillman, Corine T Neilsen, et al.
Life Science Alliance|May 20, 2020
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancerAlaknanda Adwal, Priyakshi Kalita-de Croft, Reshma Shakya, et al.
Molecular and Cellular Endocrinology|July 4, 2012
A comparison of vitamin D activity in paired non-malignant and malignant human breast tissuesRachel J Suetani, Kristen Ho, Shalini Jindal, et al.
Molecular Cancer Research : MCR|September 13, 2006
ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcriptionRaman Kumar, Jantina Manning, Hayley E Spendlove, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Human Genetics|May 19, 2004
The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 geneKavita Bhalla, Hilary A Phillips, Joanna Crawford, et al.
BMC Cancer|March 19, 2013
Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabineSue Ping Lim, Raman Kumar, Yamini Akkamsetty, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2012
Specific-site methylation of tumour suppressor ANKRD11 in breast cancerSue Ping Lim, Nick C Wong, Rachel J Suetani, et al.
American Journal of Medical Genetics|February 13, 2002
Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomaliesElizabeth Baker, Lyn Hinton, David F Callen, et al.
Journal of Cell Science|October 9, 2008
Identification of ANKRD11 as a p53 coactivatorPaul M Neilsen, Kelly M Cheney, Chia-Wei Li, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 23, 2013
Synthesis and extended activity of triazole-containing macrocyclic protease inhibitorsAshok D Pehere, Markus Pietsch, Michael Gütschow, et al.
Nucleic Acids Research|October 6, 2017
Naturally existing isoforms of miR-222 have distinct functionsFeng Yu, Katherine A Pillman, Corine T Neilsen, et al.
Life Science Alliance|May 20, 2020
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancerAlaknanda Adwal, Priyakshi Kalita-de Croft, Reshma Shakya, et al.
Molecular and Cellular Endocrinology|July 4, 2012
A comparison of vitamin D activity in paired non-malignant and malignant human breast tissuesRachel J Suetani, Kristen Ho, Shalini Jindal, et al.
Molecular Cancer Research : MCR|September 13, 2006
ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcriptionRaman Kumar, Jantina Manning, Hayley E Spendlove, et al.
Pageof 6